Tyros Biopharma

Tyros Biopharma is a privately held Canadian pharmaceutical company founded in 2011 and based in Montreal, Quebec. The company is dedicated to advancing women's health by developing, partnering, and commercializing innovative, evidence-based, and non-hormonal solutions. Its established product portfolio addresses common yet underserved conditions in intimate, vaginal, vulvar, and urinary health across different stages of life, including menopause and postpartum. Key commercial brands include Gynatrof for vaginal dryness and atrophy, Gynalac for bacterial vaginosis and pH balance, Uriexo for urinary tract infection prevention, and Gynacan boric acid capsules for recurrent yeast infections. Tyros Biopharma continues to expand its offerings with recent 2026 product launches like Gynatrof MenoControl and Uriexo Control+ to support women's wellness.